Life Science-podden: The perfect moment for an IPO

When is the right time to go for an IPO? What strategy is recommended in today´s rather uncertain business climate when it comes to taking your life science company public?

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?

In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.

The Swedish Life Science Office: “We lost in both coordination and manpower”

Since the turn of the year, the Swedish government’s life science office has operated at a lower capacity. Life Science Sweden has spoken to Pontus Holm, Depart...

Samuel Lagercrantz: A special kind of hellishness afflicts post-COVID patients

In addition to the disease itself those suffering from post-COVID have to deal with people who try to label them as hypochondriacs, writes Samuel Lagercrantz in an editorial.

Gothenburg-based company acquired by Norwegian diagnostics group

Gentian Diagnostics acquires Gothenburg-based Getica.

A green nursery for biotech rooted in the Scanian soil

Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...

Sweden is heavily criticised for not ordering Covid vaccine

Valneva and the EU Commission have entered into an agreement for 1.25 million doses of the company’s Covid vaccine, but Sweden has not placed an order.

Lundaforskare tilldelas pris från Novo Nordisk Foundation

Hindrik Mulder, professor vid Lunds universitet, får Novo Nordisk Foundation Lecture Prize för sin forskning på diabetes.

ZEISS Quality Innovation Days

The leading digital event from April 15-19, 2024.

Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...

Looking for greater Nordic cooperation – “We have Norway and Finland in our sights”

How can Medicon Valley Alliance bring the big pharmaceutical companies back to the organisation? Life Science Sweden discussed this topic and others with the cl...

A new malaria vaccine offers hope but much more research is still needed

There has long been no vaccine against malaria, but there have been breakthroughs in recent years. However, it is still unclear how we become immune to the mala...

Meeting with focus on South Korea and Japan’s life sciences

Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage ...

Nanoparticles to help detect pulmonary disease

Nanoparticles behave in a certain way in the air. Using this knowledge, researchers at Lund University have developed a new measurement method for lung examinat...

Krönika: Collaboration across borders

Första godkännandet för behandling byggd på gensaxen Crispr

För första gången har en behandling som bygger på den Nobelprisvinnande genredigeringstekniken Crispr fått ett marknadsgodkännande. Det är brittiska myndigheter...

Vinnova is going to establish a new innovation cluster

Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.

CCRM Nordic rekryterar vetenskaplig chef

Anna Falk, professor vid Lunds universitet, blir Chief Scientific Officer på CCRM Nordic.

Accurate removal of prostate tissue

Medical robots play an important role in diagnostics

This is the future location of the new national innovation cluster

Mölndal and Goco Health Innovation City will be the site of a new national innovation cluster for advanced therapies. The business community and the Swedish gov...

Valves with piezo technology

Efficient control and regulation of gases in medical technology

WHO utfärdar globalt nödläge efter mpox-utbrott

Världshälsoorganisationen WHO har återigen utlyst globalt nödläge på grund spridningen av mpox, tidigare kallat apkoppor.

Forskningscenter stoppas på grund av brister – ”Väldigt allvarligt”

Forskning som bedrivs utan tillstånd. Bristande kvalitetssäkring. Personuppgifter som hanteras felaktigt. Kritiken mot arbetet på Center for Bionics and Pain Re...